News and Media

8 BADASS PEOPLE CHANGING THE POWERSPORTS INDUSTRY

8 BADASS PEOPLE CHANGING THE POWERSPORTS INDUSTRY

October 14, 2021

Forcite Helmets one of our Stoic VC investees is one of the top innovators changing the global powersports game.
Read More
Liquid metal proven to be cheap and efficient CO2 converter

Liquid metal proven to be cheap and efficient CO2 converter

October 13, 2021

A global collaboration, led by researchers from UNSW, has shown how liquid gallium can be used to help achieve the important goal of net zero carbon emissions.
Read More
Nasal spray to treat Covid-19 enters phase 2 trials

Nasal spray to treat Covid-19 enters phase 2 trials

October 07, 2021

A nasal spray offering users protection from Covid-19 could soon be employed as another line of defence against the virus, as encouraging results from a preliminary trial of the solution trigger a second phase of studies.
Read More

A SMART Helmet with BUILT IN front CAMERA! | Forcite MK1 Smart Helmet Unboxing

A SMART Helmet with BUILT IN front CAMERA! | Forcite MK1 Smart Helmet Unboxing

September 30, 2021

One of our Stoic VC foundation investee companies continues to set the bike world on fire.
Read More
First-in-Class, Broad-Spectrum Nasal Spray to Prevent COVID-19 and Other Common Respiratory Illnesses Set to Begin Phase 2 Trials

First-in-Class, Broad-Spectrum Nasal Spray to Prevent COVID-19 and Other Common Respiratory Illnesses Set to Begin Phase 2 Trials

September 29, 2021

ENA Respiratory,a biotechnology company developing a first-in-class nasal spray for the prevention of COVID-19 and other respiratory viral infections, announced today that it has engaged research partners PPD, Inc. and hVIVO, a division of Open Orphan, to conduct its Phase 2 studies. 
Read More
Certa Therapeutics announces new clinical trial of investigative candidate

Certa Therapeutics announces new clinical trial of investigative candidate

September 22, 2021

Certa Therapeutics has announced the launch of a Phase 2 trial in Australia for a potential new treatment for Diffuse Systemic Scleroderma.
Read More